PHARMACEUTICAL FORMULATIONS, OF 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL) PYRIDIN-3-YL) -3,4-DIHYDROPYRAZINO[2,3-B]PYRAZIN-2(1H)-ONE
The present invention relates to a pharmaceutical composition comprising 1-ethyl-7-(2-methyl-6-(4H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, or a pharmaceutically acceptable salt, tautomer, isotopologue or stereoisomer thereof and one or more pharmaceutically acce...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
09.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical composition comprising 1-ethyl-7-(2-methyl-6-(4H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, or a pharmaceutically acceptable salt, tautomer, isotopologue or stereoisomer thereof and one or more pharmaceutically acceptable excipients or carriers. The present invention also relates to said composition for use in methods of treating various cancers. |
---|---|
Bibliography: | Application Number: EP20190174066 |